» Articles » PMID: 30506492

Comparability of Serum, Plasma, and Urinary Estrogen and Estrogen Metabolite Measurements by Sex and Menopausal Status

Overview
Specialties Oncology
Public Health
Date 2018 Dec 4
PMID 30506492
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: The comparability between serum, plasma, and urinary measurements of estrogen metabolites via liquid chromatography-tandem mass spectrometry (LC-MS/MS) has not been largely explored, and it is unclear if urinary LC-MS/MS measurements are suitable surrogates of circulating levels.

Methods: Serum, plasma (EDTA and heparin), and urinary estrogen/estrogen metabolite levels were measured via LC-MS/MS in paired samples from 64 healthy volunteers (18 men, 20 premenopausal women, 26 postmenopausal women). Geometric means and Spearman correlation coefficients were used to compare individual and combined pathway levels of estrogens/estrogen metabolites across biologic matrices by sex/menopausal status.

Results: Measured concentrations of estrogens/estrogen metabolites across blood matrices were almost identical (percent differences < 4.8%). Parent estrogen concentrations measured in serum and urine were moderately correlated in postmenopausal women (estrone: r = 0.69, estradiol: r = 0.69). Correlations were similar comparing unconjugated serum estradiol to urinary estrone (r = 0.76) and urinary estradiol (r = 0.65) in postmenopausal women but were moderate to low in premenopausal women (r = 0.60, 0.40, respectively)/men (r = 0.33, 0.53, respectively). Comparing metabolite ratios, proportionally higher concentrations of 16-pathway metabolites were measured in urine versus serum across sex/menopausal status groups (e.g., postmenopausal women: 50.3% 16-pathway metabolites/total in urine versus 35.3% in serum).

Conclusions: There is strong agreement between estrogen/estrogen metabolites measurements in serum, heparin plasma, and EDTA plasma. Individual estrogen metabolite concentrations were moderately correlated between urine and serum, but were not well correlated when evaluating pathway- or relative estrogen concentrations. Differences between serum and urine are likely explained by differences in metabolism and/or excretion.

Citing Articles

Associations of tubal ligation and hysterectomy with serum androgen and estrogen metabolites among postmenopausal women in the Women's Health Initiative Observational Study.

Geczik A, Michels K, Anderson G, Falk R, Farland L, Manson J Cancer Causes Control. 2024; 35(9):1283-1295.

PMID: 38772931 PMC: 11441446. DOI: 10.1007/s10552-024-01882-4.


Gut Microbiome-Estrobolome Profile in Reproductive-Age Women with Endometriosis.

Pai A, Wang Y, Lu P, Wu H, Xu J, Huang H Int J Mol Sci. 2023; 24(22).

PMID: 38003489 PMC: 10671785. DOI: 10.3390/ijms242216301.


Associations of Circulating Estrogens and Estrogen Metabolites with Fecal and Oral Microbiome in Postmenopausal Women in the Ghana Breast Health Study.

Wu Z, Pfeiffer R, Byrd D, Wan Y, Ansong D, Clegg-Lamptey J Microbiol Spectr. 2023; 11(4):e0157223.

PMID: 37341612 PMC: 10433996. DOI: 10.1128/spectrum.01572-23.


Epigenetic prediction of 17β-estradiol and relationship to trauma-related outcomes in women.

Hack L, Nishitani S, Knight A, Kilaru V, Maddox S, Seligowski A Compr Psychoneuroendocrinol. 2022; 6:100045.

PMID: 35757356 PMC: 9216622. DOI: 10.1016/j.cpnec.2021.100045.


Associations of body shape phenotypes with sex steroids and their binding proteins in the UK Biobank cohort.

Christakoudi S, Riboli E, Evangelou E, Tsilidis K Sci Rep. 2022; 12(1):10774.

PMID: 35750890 PMC: 9232606. DOI: 10.1038/s41598-022-14439-9.


References
1.
Key T, Appleby P, Barnes I, Reeves G . Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies. J Natl Cancer Inst. 2002; 94(8):606-16. DOI: 10.1093/jnci/94.8.606. View

2.
OConnor K, Brindle E, Holman D, Klein N, Soules M, Campbell K . Urinary estrone conjugate and pregnanediol 3-glucuronide enzyme immunoassays for population research. Clin Chem. 2003; 49(7):1139-48. DOI: 10.1373/49.7.1139. View

3.
Kesner J, Wright D, Schrader S, Chin N, Krieg Jr E . Methods of monitoring menstrual function in field studies: efficacy of methods. Reprod Toxicol. 1992; 6(5):385-400. DOI: 10.1016/0890-6238(92)90002-b. View

4.
Xu X, Veenstra T, Fox S, Roman J, Issaq H, Falk R . Measuring fifteen endogenous estrogens simultaneously in human urine by high-performance liquid chromatography-mass spectrometry. Anal Chem. 2005; 77(20):6646-54. DOI: 10.1021/ac050697c. View

5.
Eliassen A, Missmer S, Tworoger S, Spiegelman D, Barbieri R, Dowsett M . Endogenous steroid hormone concentrations and risk of breast cancer among premenopausal women. J Natl Cancer Inst. 2006; 98(19):1406-15. DOI: 10.1093/jnci/djj376. View